DJ Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ advanced 2.47% to $58.80 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.59% to 5,861.57 and Dow Jones Industrial Average falling 0.45% to 43,239.50.
Bristol Myers Squibb Co. closed 3.76% short of its 52-week high of $61.10, which the company achieved on January 27th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 0.40% to $163.73, Pfizer Inc. $(PFE)$ fell 1.21% to $26.10, and Abbott Laboratories $(ABT)$ fell 0.07% to $135.87.
Trading volume (9.6 M) remained 1.8 million below its 50-day average volume of 11.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 27, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 27, 2025 16:39 ET (21:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。